GNH USA

Europe — EMA

Mestinon

GNH USA supplies Mestinon (Pyridostigmine bromide), an acetylcholinesterase inhibitor for myasthenia gravis. Request a quote for global supply to clinics.

Pyridostigmine Bromide

Request sourcing

1
Pack/s

What is Pyridostigmine Bromide?

Pyridostigmine bromide, the active ingredient in Mestinon, is an acetylcholinesterase inhibitor presented as an oral tablet for oral use. It is employed to improve muscle strength in patients with myasthenia gravis. GNH USA supplies Mestinon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Pyridostigmine Bromide used for?

Mestinon is an acetylcholinesterase inhibitor indicated for disorders of neuromuscular transmission, particularly myasthenia gravis.

- Myasthenia gravis: improves skeletal muscle strength and reduces fatigue in affected individuals.

What are the side effects of Pyridostigmine Bromide?

Mestinon may cause a range of adverse reactions, most of which are dose‑related and reversible upon dose adjustment.

Common Side Effects: - Nausea - Diarrhea - Abdominal cramps - Increased salivation - Muscle cramps - Sweating

Serious or Rare Side Effects: - Cholinergic crisis (muscle weakness, respiratory failure) - Bradycardia - Bronchospasm - Allergic rash or urticaria - Respiratory depression - Seizures

What precautions apply to Pyridostigmine Bromide?

Before initiating therapy, clinicians should consider several safety aspects to minimise risk.

- Dose adjustment: required in renal impairment to avoid accumulation. - Monitor: for signs of cholinergic excess such as muscle twitching or excessive secretions. - Avoid: concomitant use with strong anticholinergic agents that may counteract efficacy. - Caution: in patients with asthma, COPD, or other obstructive airway diseases. - Pregnancy: safety not established; use only if potential benefit justifies the risk. - Store at below 25°C: keep in the original pack, protect from moisture.

What does Pyridostigmine Bromide interact with?

Pyridostigmine can interact with several drug classes, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Anticholinergic agents: may diminish therapeutic effect. - Beta‑blockers: can exacerbate bradycardia. - Neuromuscular blocking drugs: increase risk of prolonged paralysis.

Moderate Interactions (Monitor Closely): - Beta‑2 agonists: may heighten cholinergic symptoms. - Magnesium supplements: can enhance neuromuscular blockade. - Other cholinesterase inhibitors: additive cholinergic activity may occur.

Frequently asked questions

What is Mestinon used for?+
Mestinon (pyridostigmine bromide) is prescribed primarily for myasthenia gravis, a chronic autoimmune disorder that causes fluctuating muscle weakness. By enhancing neuromuscular transmission, the medication helps patients achieve better muscle strength and reduces fatigue during daily activities.
How does pyridostigmine work?+
Pyridostigmine inhibits the enzyme acetylcholinesterase, which normally breaks down acetylcholine at the neuromuscular junction. The inhibition raises acetylcholine levels, allowing more sustained stimulation of nicotinic receptors on skeletal muscle fibers, thereby improving muscle contraction strength.
What is the usual dose of Mestinon?+
The dosage of Mestinon is individualized and must be determined by a qualified prescriber based on the patient’s clinical condition, severity of symptoms, renal function, and response to therapy. Patients should follow the dosing instructions provided by their healthcare professional.
Is Mestinon safe during pregnancy or breastfeeding?+
Safety data for pyridostigmine in pregnancy and lactation are limited. It should be used only if the potential therapeutic benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and benefits with their physician.
How do I order Mestinon from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Mestinon compare with other treatments for myasthenia gravis?+
Mestinon belongs to the class of reversible acetylcholinesterase inhibitors, similar to neostigmine but with a longer duration of action and better oral bioavailability. Compared with immunosuppressive therapies, it provides symptomatic relief without altering the underlying immune response, making it a first‑line symptomatic option.
How should Mestinon be stored and handled?+
Mestinon tablets should be stored at temperatures below 25 °C, in their original container, and protected from moisture and direct sunlight. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.
How is Mestinon administered?+
Mestinon is taken orally, usually with a glass of water. It can be taken with or without food, but consistent timing relative to meals helps maintain stable blood levels. Patients should not crush or chew the tablets unless specifically instructed by a healthcare professional.
What are the most serious risks associated with Mestinon?+
The most critical risks include cholinergic crisis, which can present as severe muscle weakness, respiratory failure, and bradycardia, as well as bronchospasm and seizures. Prompt medical attention is required if any of these symptoms develop.
Who should not use Mestinon?+
Mestinon is contraindicated in individuals with known hypersensitivity to pyridostigmine or any component of the formulation. Patients with severe asthma, chronic obstructive pulmonary disease, or those taking potent anticholinergic drugs should avoid it unless closely supervised by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Pyridostigmine Bromide
Route
Oral Use
Manufacturer
Viatris Healthcare Limited
Origin
EU

Related products